These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20171982)

  • 1. Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications.
    Lambert GW; Straznicky NE; Lambert EA; Dixon JB; Schlaich MP
    Pharmacol Ther; 2010 May; 126(2):159-72. PubMed ID: 20171982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediators of sympathetic activation in metabolic syndrome obesity.
    Straznicky NE; Eikelis N; Lambert EA; Esler MD
    Curr Hypertens Rep; 2008 Dec; 10(6):440-7. PubMed ID: 18959829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?
    Lambert EA; Straznicky NE; Dixon JB; Lambert GW
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H244-58. PubMed ID: 25980020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome.
    Lambert EA; Lambert GW
    Curr Hypertens Rep; 2011 Jun; 13(3):244-8. PubMed ID: 21271362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and adipokines: effects on sympathetic overactivity.
    Smith MM; Minson CT
    J Physiol; 2012 Apr; 590(8):1787-801. PubMed ID: 22351630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary hypertension: obesity and the metabolic syndrome.
    Singer GM; Setaro JF
    J Clin Hypertens (Greenwich); 2008 Jul; 10(7):567-74. PubMed ID: 18607142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural mechanisms and management of obesity-related hypertension.
    Esler MD; Eikelis N; Lambert E; Straznicky N
    Curr Cardiol Rep; 2008 Nov; 10(6):456-63. PubMed ID: 18950554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the metabolic syndrome be explained by a unifying concept?
    Hjemdahl P
    Lancet Diabetes Endocrinol; 2015 Feb; 3(2):96-8. PubMed ID: 25618291
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic inflexibility in skeletal muscle: a prelude to the cardiometabolic syndrome?
    Thyfault JP; Rector RS; Noland RC
    J Cardiometab Syndr; 2006; 1(3):184-9. PubMed ID: 17679820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic activity in obesity: a brief review of methods and supportive data.
    Lambert GW; Schlaich MP; Eikelis N; Lambert EA
    Ann N Y Acad Sci; 2019 Oct; 1454(1):56-67. PubMed ID: 31268175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome: a sympathetic disease?
    Schlaich M; Straznicky N; Lambert E; Lambert G
    Lancet Diabetes Endocrinol; 2015 Feb; 3(2):148-57. PubMed ID: 24731670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sympathetic nervous system and the metabolic syndrome.
    Mancia G; Bousquet P; Elghozi JL; Esler M; Grassi G; Julius S; Reid J; Van Zwieten PA
    J Hypertens; 2007 May; 25(5):909-20. PubMed ID: 17414649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
    Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
    J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome.
    Thorp AA; Schlaich MP
    J Diabetes Res; 2015; 2015():341583. PubMed ID: 26064978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial function masks increased sympathetic vasopressor activity in rats with metabolic syndrome.
    Battault S; Meziat C; Nascimento A; Braud L; Gayrard S; Legros C; De Nardi F; Drai J; Cazorla O; Thireau J; Meyer G; Reboul C
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H497-H507. PubMed ID: 29127233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training dose differentially alters muscle and heart capillary density and metabolic functions in an obese rat with metabolic syndrome.
    Machado MV; Vieira AB; da Conceição FG; Nascimento AR; da Nóbrega ACL; Tibirica E
    Exp Physiol; 2017 Dec; 102(12):1716-1728. PubMed ID: 28921743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms mediating renal sympathetic activation to leptin in obesity.
    Morgan DA; Thedens DR; Weiss R; Rahmouni K
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1730-6. PubMed ID: 18815209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent hypoxia and diet-induced obesity: effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure.
    Olea E; Agapito MT; Gallego-Martin T; Rocher A; Gomez-Niño A; Obeso A; Gonzalez C; Yubero S
    J Appl Physiol (1985); 2014 Oct; 117(7):706-19. PubMed ID: 25103975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.